SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-11
👔
HARVARD BIOSCIENCE INC
@HBIO_InsiderForm 4 Filing: Gagnon Robert E. Acquires (Grant) shares of $HBIO
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
HARVARD BIOSCIENCE INC
Ticker: $HBIO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-09
Shares: 16,556
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Gagnon Robert E., holds the title of Director at HARVARD BIOSCIENCE INC.
On 2026-06-09, the insider transacted 16,556 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Gagnon Robert E. (Director) was granted $0 of $HBIO
Post-Transaction Position: 27,556 shares
SEC Accession No: 0001171843-26-004057 (CIK: 1504983)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.